Thursday's trading session is witnessing notable movements in stocks across the board, particularly in the mega-cap and large-cap categories. Some stocks are experiencing significant gains post-earnings announcements, while others are facing sharp declines due to various factors. Here's a look at some of the most significant movers in today's market, from the largest companies by market cap to smaller firms making waves.

Mega-Cap Movers (Market Cap $200B+):

• Accenture Ltd (NYSE: ACN ): Accenture Reports First-Quarter Fiscal 2025 Results; +7.48%
• Nvidia Corp (NASDAQ: NVDA ): +3.01%
• Oracle Corp (NYSE: ORCL ): +3.15%

Large-Cap Stock Movers (Market Cap $10B-$200B):

• Darden Restaurants (NYSE: DRI ): Darden Restaurants Reports Fiscal 2025 Second Quarter Results; Declares Quarterly Dividend; And Updates Fiscal 2025 Financial Outlook; +15.46%
• Lamb Weston Holdings Inc (NYSE: LW ): Lamb Weston reports dip in Q2 earnings, trims outlook; -20.85%
• Micron Tech (MU): Micron Technology (NASDAQ: MU ), Inc. Reports Results for the First Quarter of Fiscal 2025; -16.21%
• Vertex Pharm (NASDAQ: VRTX ): Vertex reports mixed results in Phase 2 pain study; -11.95%
• Cintas Corp (NASDAQ: CTAS ): Cintas stock edges higher on Q2 earnings beat, raised full-year outlook; -9.09%
• Summit Therapeutics PLC (NASDAQ: SMMT ): +8.33%
• MSTU (MSTU): -8.19%
• FBTC NYSE (FBTC): -1.81%

Mid-Cap Stock Movers (Market Cap $2B-$10B):

• Quantum (NASDAQ: QMCO ) Computing OTC (QUBT): -43.61%
• Rigetti Computing Inc (NASDAQ: RGTI ): -29.38%
• DPCM Capital (QBTS): -28.91%
• AltC Acquisition (OKLO): +14.91%
• C3 Ai Inc (NYSE: AI ): -11.26%
• BITX (BITX): -4.35%
• MSTZ (MSTZ): +9.32%
• Oaktree Acquisition Corp (NYSE: HIMS ): -9.7%
• SoundHound AI (NASDAQ: SOUN ): -9.23%
• Joby Aviation (NYSE: JOBY ): -7.35%

Small-Cap Stock Movers (Market Cap $300M-$2B):

• Membership Collective Group (SHCO): +58.25%
• Omeros Corp (NASDAQ: OMER ): Omeros reports survival benefit with narsoplimab in TA-TMA; +35.39%
• Prothena Corporation PLC (PRTA): Roche's Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson's Disease; +40.67%
• Centricus Acquisition (ARQQ): -29.73%
• Cango Inc (NYSE: CANG ): -27.13%
• Tuscan Holdings Corp (MVST): +28.26%
• UVIX (UVIX): +13.32%
• Flame Acquisition (SOC): +16.22%
• CMI Acquisition LLC (SKYT): -16.62%
• Innodata Isogen (INOD): +15.53%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.